Publications
News
-
20 February 2025Gorodissky & Partners hosted a business breakfast dedicated to the information support of innovation activities, which was attended by about 40 specialists in the field of intellectual property.
All News
Publications
-
28 January 2025
In the article the author reports on the challenge of the Eurasian patent #024421 for the drug Osimertinib between the right holder AstraZeneca and the Russian drug manufacturer Axelpharm.
All Publications
«Gorodissky» in media
-
3 February 2021
Sergey Medvedev, Partner at Gorodissky & Partners, gave the following comment to Practical Law by Thomson Reuters on what to expect in 2021 in Pharma: “The use of the patented technologies and inventions for the benefit of national security in the pharma sphere should become a hot issue. The Russian government has already issued a binding order under Article 1360 of the Russian Civil Code to allow the use of inventions related to the production of Remdesivir...
All «Gorodissky» in media
Events
-
Valery Narezhny, Ph.D., Counsel (Gorodissky & Partners, Moscow) will speak at the seminar ‘Intellectual Property Rights: Practice of Applying Part IV of the Civil Code of the Russian Federation’ organised by the Centre for Innovative Development ‘Delovoye Obrazovanie.ru’.
All Events
G-newsletters
Legal updates
-
Starting October 5, 2024 the amendments to the Regulations on Patent and Other Fees of the Russian PTO approved by Decree of the Government of the Russian Federation No. 1278 dated September 18, 2024, came into effect.
All Legal updates
